- Home
- VMC vs BDX Comparison
VMC vs BDX Comparison
Compare VMC & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VMC | BDX |
|---|---|---|
| Founded | 1909 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2B | 43.0B |
| IPO Year | 2007 | 1997 |
Fundamental Metrics
Financial Performance| Metric | VMC | BDX |
|---|---|---|
| Price | $285.92 | $153.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $323.17 | $186.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | 0.70% | ★ 2.89% |
| EPS Growth | ★ 18.39 | N/A |
| EPS | ★ 1.26 | 0.25 |
| Revenue | $7,781,900,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $1.85 | N/A |
| Revenue Next Year | $6.22 | $3.02 |
| P/E Ratio | ★ $238.31 | $625.88 |
| Revenue Growth | 6.38 | ★ 8.24 |
| 52 Week Low | $252.35 | $140.11 |
| 52 Week High | $331.09 | $213.08 |
Technical Indicators
Market Signals| Indicator | VMC | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 53.38 |
| Support Level | $279.29 | $141.69 |
| Resistance Level | $300.42 | $153.09 |
| Average True Range (ATR) | 9.64 | 4.05 |
| MACD | -1.56 | 0.80 |
| Stochastic Oscillator | 0.75 | 64.91 |
Price Performance
Historical ComparisonAbout VMC Vulcan Materials Company (Holding Company)
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6 million cubic yards of ready-mix. As of Dec. 31, 2024, the company had 16.5 billion tons of aggregate reserves.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.